LH

Laboratory
D

LH

Arincen56/100B

Laboratory cash on hand 1989–2026

Laboratory had 261.80M USD in cash and short-term investments on 30 September 2026, down 56.2% on a year before. At the end of fiscal year 2025 it had 532.30M USD.

Last updated 6 Nov 2026 · Next report 16 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 2026261.80M-56.23%6.78B-6.51B
FY202531 Dec 2025532.30M-64.95%7.20B-6.67B
FY202431 Dec 20241.52B+182.92%7.27B-5.75B
FY202331 Dec 2023536.80M+67.44%5.95B-5.42B
FY202231 Dec 2022320.60M-78.23%6.25B-5.93B
FY202131 Dec 20211.47B+11.50%6.34B-4.87B
FY202031 Dec 20201.32B+291.35%6.76B-5.44B
FY201931 Dec 2019337.50M-20.92%7.11B-6.77B
FY201831 Dec 2018426.80M+34.81%6.06B-5.63B
FY201731 Dec 2017316.60M-26.98%6.76B-6.45B
FY201631 Dec 2016433.60M-39.48%5.85B-5.42B
FY201531 Dec 2015716.40M+23.52%6.36B-5.65B
FY201431 Dec 2014580.00M+43.56%3.03B-2.45B
FY201331 Dec 2013404.00M-13.45%3.00B-2.60B
FY201231 Dec 2012466.80M+193.03%2.66B-2.19B
FY201131 Dec 2011159.30M-30.95%2.22B-2.06B
FY201031 Dec 2010230.70M+55.35%2.19B-1.96B
FY200931 Dec 2009148.50M-32.41%1.39B-1.25B
FY200831 Dec 2008219.70M+32.11%1.72B-1.50B
FY200731 Dec 2007166.30M-11.02%1.67B-1.50B
FY200631 Dec 2006186.90M+196.20%1.16B-970.50M
FY200531 Dec 200563.10M-69.49%1.15B-1.09B
FY200431 Dec 2004206.80M+68.13%892.30M-685.50M
FY200331 Dec 2003123.00M+118.09%884.20M-761.20M
FY200231 Dec 200256.40M-62.20%521.90M-465.50M
FY200131 Dec 2001149.20M+205.74%508.90M-359.70M
FY200031 Dec 200048.80M+21.09%485.70M-436.90M
FY199931 Dec 199940.30M+77.53%577.80M-537.50M
FY199831 Dec 199822.70M-2.58%648.00M-625.30M
FY199731 Dec 199723.30M-20.48%689.60M-666.30M
FY199631 Dec 199629.30M+78.66%1.28B-1.25B
FY199531 Dec 199516.40M-38.81%1.01B-994.50M
FY199431 Dec 199426.80M+117.89%602.80M-576.00M
FY199331 Dec 199312.30M-63.17%320.80M-308.50M
FY199231 Dec 199233.40M-34.89%145.50M-112.10M
FY199131 Dec 199151.30M+12.01%0.0051.30M
FY199031 Dec 199045.80M+43.12%22.00M23.80M
FY198931 Dec 198932.00M—0.0032.00M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Laboratory's cash

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.